Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.470
+0.110 (3.27%)
At close: May 29, 2026, 4:00 PM EDT
3.300
-0.170 (-4.89%)
After-hours: May 29, 2026, 4:52 PM EDT
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 11 employees as of December 31, 2025. The number of employees decreased by 2 or -15.38% compared to the previous year.
Employees
11
Change (1Y)
-2
Growth (1Y)
-15.38%
Revenue / Employee
n/a
Profits / Employee
-$781,109
Market Cap
2.25M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | -2 | -15.38% |
| Dec 31, 2024 | 13 | -8 | -38.10% |
| Dec 31, 2023 | 21 | -6 | -22.22% |
| Dec 31, 2022 | 27 | 7 | 35.00% |
| Dec 31, 2021 | 20 | 2 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Calidi Biotherapeutics | 29 |
| Silexion Therapeutics | 14 |
| Ensysce Biosciences | 10 |
| Adial Pharmaceuticals | 5 |
| GRI Bio | 4 |
BDRX News
- 15 days ago - Biodexa issues letter to Shareholders - GlobeNewsWire
- 2 months ago - Biodexa Pharmaceuticals PLC-ADR trading halted, news pending - TheFly
- 2 months ago - Biodexa Pharmaceuticals announces MTX240 manufacturing pact with Syngene - TheFly
- 2 months ago - Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies - GlobeNewsWire
- 2 months ago - Biodexa, Tanner Pharma launch global early access program for FAP patients - TheFly
- 2 months ago - Preliminary Results for the Year Ended 31 December 2025 - GlobeNewsWire
- 2 months ago - Biodexa Pharmaceuticals management to meet with Maxim - TheFly
- 2 months ago - Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group - GlobeNewsWire